Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 103Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Myelodysplastic Syndromes 89Leukemia 79Lymphoma 71Lymphoma, Non-Hodgkin 70Leukemia, Lymphocytic, Chronic, B-Cell 65Hodgkin Disease 55Multiple Myeloma 49Lymphoma, Mantle-Cell 42Lymphoma, Follicular 41Burkitt Lymphoma 39Lymphoma, Large B-Cell, Diffuse 38Lymphoma, B-Cell, Marginal Zone 36Lymphoma, Large-Cell, Immunoblastic 33Myeloproliferative Disorders 32Hematologic Neoplasms 32Leukemia, Myelogenous, Chronic, BCR-ABL Positive 30Neoplasms, Plasma Cell 27Leukemia, Myeloid, Accelerated Phase 25Leukemia, Myeloid, Chronic-Phase 24Congenital Abnormalities 24Leukemia, Myelomonocytic, Chronic 23Graft vs Host Disease 22Dendritic Cell Sarcoma, Interdigitating 21Recurrence 20Anemia, Refractory, with Excess of Blasts 20Waldenstrom Macroglobulinemia 18Blast Crisis 18Primary Myelofibrosis 17

Interventions

entinostat 1Radiotherapy 1Methylprednisolone 1Melphalan 1Imatinib Mesylate 1Fentanyl 1Cyclosporine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thymoma × Melphalan × Other hematologic neoplasm × Clear all
NCT00003662 2011-03-07

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

Roswell Park Cancer Institute

Phase 2 Completed
90 enrolled
Classical hematologyMyeloidOther hematologic neoplasmThoracic

Anemia, Refractory, Graft vs Host Disease, Leukemia, Myelodysplastic Syndromes, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡